Comparison of wild type with recombinant Clostridium difficile toxin A

Area of Science:

• Microbiology
• Molecular Biology
• Toxicology

Background:

• Clostridium difficile toxins A and B are key virulence factors.
• These toxins target Rho GTPase family proteins.
• High purity is essential for their use as Rho GTPase inhibitors.

Purpose of the Study:

• To express and characterize recombinant His-tagged toxin A.
• To compare the properties of recombinant toxin A with native toxin A.
• To assess the suitability of recombinant toxin A as a purified inhibitor.

Main Methods:

• Expression of recombinant His-tagged toxin A in Bacillus megaterium.
• Generation of specific antisera for toxin A.
• Western blot and ELISA for antibody specificity.
• Cytotoxicity and glucosyltransferase activity assays.
• Mitochondrial release of cytochrome c assays.

Main Results:

• Recombinant toxin A exhibited 2-fold higher cytotoxicity and 10-fold increased glucosyltransferase activity compared to native toxin A.
• Antisera showed identical specificity and sensitivity for both native and recombinant toxins.
• The transferase-independent release of cytochrome c from mitochondria, observed with native toxin A, was absent in recombinant toxin A.
• The mitochondrial effect in native toxin A decreased with increasing purity, implicating contamination.

Conclusions:

• Recombinant toxin A is a suitable substitute for native toxin A.
• The recombinant toxin offers advantages of rapid single-step purification.
• Recombinant toxin A lacks biological contaminants, including the mitochondrial-disrupting factor.
• The previously reported mitochondrial effect of toxin A is likely due to contamination.